The United States Food and Drug Administration has granted tentative approval to United States-based Perrigo's generic version of
Suprep (sodium sulphate/potassium sulphate/magnesium sulphate) oral solution, it was reported yesterday.
M2 EQUITYBITES-August 24, 2016-Perrigo wins tentative US FDA approval for generic
Suprep Oral Solution; Confirms patent challenge for generic Mirvaso Gel
M2 PHARMA-August 24, 2016-Perrigo wins tentative US FDA approval for generic
Suprep Oral Solution; Confirms patent challenge for generic Mirvaso Gel